MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Basal ganglia"

  • 2023 International Congress

    Comparative Effects of Medical Treatment and Tension Deactivation Via Electromyography Biofeedback Intervention to Improve Maximum Mouth Opening in Individuals With Bruxism

    MYA. Amine, U. El-Dakrory (Giza, Egypt)

    Objective: comparing the effects of muscle relaxants and NSAIDs with EMG biofeedback in improving maximum mouth opening in bruxism. Background: Bruxism is an extrapyramidal system…
  • 2023 International Congress

    Failure of model-based outcome monitoring in Parkinson’s Disease Apathy

    W. Gilmour, G. Mackenzie, M. Feile, A. Macleod, V. Marshall, D. Steele, T. Gilbertson (Dundee, United Kingdom)

    Objective: To investigate the neural basis of apathy in Parkinson’s Disease (PD). Background: Apathy is a debilitating and poorly understood syndrome characterised by a reduction…
  • 2022 International Congress

    DBS Experience In A Pediatric Neurowilson Case

    S. Bozkaya Yilmaz, N. Olgaç Dündar, G. Basarir, P. Gencpinar, A. Ersen (Izmir, Turkey)

    Objective: I have chosen this case to demonstrate an atypical presentation of Neuro-Wilson disease without a prominent hepatic involvement. I have also aimed to call…
  • 2022 International Congress

    Myoclonus – encephalopathy induced by ifosfamide in a Non-Hodgkin lymphoma patient

    D. Rebolledo García (Mexico City, Mexico)

    Objective: Describe a clinical vignette about toxicity by ifosfamide in a man with follicular lymphoma (FL) that presented myoclonus and altered consciousness six hours after…
  • 2022 International Congress

    Determination of glycine transporter 1 levels with [3H]-NFPS binding in hemi-parkinsonian rats with L-DOPA induced dyskinesia

    I. Frouni, D. Bédard, E. Kim, S. Belliveau, C. Kwan, P. Huot (Montreal, Canada)

    Objective: To determine the distribution of the glycine transporter 1 (GlyT1) in brain areas implicated in parkinsonism and L-3,4-dihydroxyphenylalanine (L-DOPA) induced dyskinesia in the 6-hydroxydopamine…
  • 2022 International Congress

    Enabling Multi-domain Exercise Training in Parkinson’s Disease Through Wearable and Digital Health Technology

    B. Hu, T. Chomiak (Calgary, Canada)

    Objective: This study investigated whether Ambulosono, a multi-domain exercise platform, could serve as a disease modifying therapy for Parkinson’s disease (PD). Background: Regular exercise has…
  • 2022 International Congress

    Delayed post-stroke parkinsonism: description of two cases and possible mechanism

    T. Friedeman- Korn, M. Bauer, M. Abu Snineh, C. Weill, D. Arkadir (Jerusalem, Israel)

    Objective: To present two patients who developed delayed parkinsonism years after experiencing midbrain strokes and to suggest a possible mechanism for this delayed phenomenon. Background:…
  • 2022 International Congress

    Neurodegeneration associated with pantothenate kinase in a Mexican Patient: Solving the Diagnostic Challenge of the Eye of Tiger

    M. Arbeu Reyes, B. Madariaga Cortés, C. Aguilar Vázquez (Mexico City, Mexico)

    Objective: To describe the case of a patient with PKAN in Mexico, where we have a few information about inherited movement disorders, which makes the…
  • 2022 International Congress

    Covid vaccine induced parkinsonism and cognitive dysfunction

    R. Dhamija, P. Talwar, S. Kushwaha, K. Gowdar (Delhi, India)

    Objective: To describe movement disorder and cognitive impairment in two patients following COVID-19 vaccination. Background: The manifestation of neurological complications have been increasingly evidenced following…
  • 2022 International Congress

    The role of cortical and subcortical structures in maintaining efficient network topology in Parkinson’s disease

    R. Berlot, B. Koritnik, Z. Pirtošek (Ljubljana, Slovenia)

    Objective: To assess the relative importance of cortical and subcortical nodes and their connections in maintaining efficient structural connectome topology in Parkinson's disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley